YSEI SHH-300GD-2 Pharmaceutical Photostability Testing Chamber

Overview

The YSEI SHH-300GD-2 Pharmaceutical Photostability Testing Chamber is an engineered environmental simulation system designed specifically for photostability assessment of drug substances and products under controlled irradiation conditions. It operates on the principle of accelerated light exposure testing, applying calibrated broadband visible and near-ultraviolet radiation to replicate long-term sunlight-induced degradation pathways—critical for identifying photochemical decomposition, color shifts, potency loss, or formation of potentially genotoxic impurities. The chamber complies with internationally harmonized regulatory frameworks including ICH Q1B (Photostability Testing of New Drug Substances and Products), U.S. FDA Guidance for Industry (Photosensitivity Testing), and the “Guideline on Stability Testing of Chemical Drugs” stipulated in the Chinese Pharmacopoeia (2015 Edition). Its design centers on metrological traceability, thermal-radiative coupling stability, and operational robustness—ensuring reproducible irradiance profiles across extended test durations (e.g., 1.2×10⁶ lux·h total visible dose and ≥200 W·h/m² near-UV energy, as mandated by ICH Q1B Option 1).

Key Features

• Regulatory-aligned optical architecture: Integrated high-stability xenon arc or fluorescent lamp array (configuration dependent on model variant), spectrally filtered to emulate daylight UV–visible spectrum (290–800 nm), with real-time irradiance monitoring and closed-loop intensity compensation.
• Thermally decoupled irradiation chamber: Precision air-cooled refrigeration system maintains setpoint temperature (typically 25°C ±2°C) independent of radiant heat load—minimizing thermal artifacts during photolysis studies.
• Dual-redundant data integrity system: Synchronized recording via built-in thermal printer (user-configurable print interval) and timestamped digital acquisition through RS485 serial interface; all logged parameters include irradiance (lux), chamber temperature (°C), runtime (h), and UV energy accumulation (W·h/m²).
• Centralized networked operation: Supports Modbus RTU protocol over TCP/IP; a single Windows-based host can monitor, configure, and validate up to 30 SHH-GD series units simultaneously—enabling cross-lab cohort studies and unified audit trail generation.
• Hardware-level safety interlocks: Independent temperature limiter circuit interrupts power to heating/cooling elements if chamber exceeds preset threshold; dedicated compressor current monitoring prevents thermal runaway during sustained operation.

Sample Compatibility & Compliance

The SHH-300GD-2 accommodates standard pharmaceutical packaging formats—including open petri dishes, amber vials, blister cards, and unpackaged reference standards—mounted on removable light-diffusing shelves (one shelf included; optional multi-tier configurations available). All internal surfaces are non-reflective and UV-stable to prevent secondary irradiation artifacts. The system meets essential compliance requirements for GLP- and GMP-regulated environments: full alignment with ICH Q1B Options 1 and 2, FDA 21 CFR Part 11 readiness (when paired with validated software), and Chinese Pharmacopoeia General Chapter “Stability Testing of Drug Substances and Products.” Optional IQ/OQ protocols—pre-written, editable, and executed by YSEI-certified field engineers—facilitate regulatory submission readiness and facility qualification.

Software & Data Management

Data acquisition is managed via YSEI’s proprietary PhotostabLink™ software (Windows 10/11 compatible), supporting real-time graphing of irradiance drift, temperature deviation, and cumulative UV dose. Raw logs export to CSV or PDF with embedded digital signatures. Audit trail functionality records all user actions (login/logout, parameter changes, manual overrides) with immutable timestamps—satisfying ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available). Remote firmware updates and diagnostic telemetry are accessible via secure HTTPS tunnel, enabling proactive maintenance without on-site intervention.

Applications

• ICH Q5C-compliant photostability screening of biologics (mAbs, recombinant proteins) in liquid and lyophilized formulations.
• Forced degradation studies per ICH Q5A(R2) to identify light-sensitive impurities and establish protective packaging specifications.
• Comparative evaluation of UV-filtering excipients (e.g., titanium dioxide, iron oxides) in topical suspensions and ointments.
• Validation of amber glass vs. opaque polymer container performance under standardized irradiance profiles.
• Supporting ANDA submissions requiring demonstration of photostability per FDA CDER guidance (2022).

FAQ

Does the SHH-300GD-2 meet ICH Q1B Option 2 requirements for near-UV irradiance monitoring?
Yes—the system integrates a NIST-traceable UV-A radiometer (320–400 nm) with automatic compensation for lamp aging and filter degradation, ensuring continuous compliance with ≥200 W·h/m² near-UV dose.
Can raw irradiance data be exported for statistical process control (SPC) analysis?
Yes—CSV exports include second-by-second irradiance, temperature, and elapsed time columns, fully compatible with JMP, Minitab, and Python pandas workflows.
Is the thermal printer module compliant with 21 CFR Part 11 electronic record requirements?
The printer serves as a supplementary hardcopy output; primary compliance relies on the digitally signed, audit-trail-enabled PC-based data archive—fully Part 11 compliant when deployed with appropriate access controls and electronic signatures.
What validation documentation is included with purchase?
Standard delivery includes Factory Acceptance Test (FAT) report, User Requirement Specification (URS) cross-reference matrix, and template IQ/OQ protocols. Full execution with witness reports is available as a billable service.
How is lamp spectral output verified during routine qualification?
YSEI provides a calibrated spectroradiometer loan program and annual lamp spectral certification service—validating spectral match to CIE Illuminant D65 within ±5% across 290–800 nm per ISO/CIE 17166:2022.